Tocilizumab in severe COVID-19: A promise fulfilled

被引：6
|
作者：
Levi, Marcel [1 ,2 ,3 ]
机构：
[1] Univ Amsterdam, Dept Vasc Med, Med Ctr, Amsterdam, Netherlands
[2] Univ Coll London Hosp NHS Fdn Trust, Dept Med, London, England
[3] Cardiometab Programme NIHR UCLH UCL BRC, London, England
来源：
EUROPEAN JOURNAL OF INTERNAL MEDICINE | 2022年 / 95卷
关键词：
D O I：
10.1016/j.ejim.2021.11.015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：38 / 39
页数：2
相关论文
共 50 条
  • [1] Tocilizumab in severe COVID-19
    Liberato, Nicola Lucia
    De Monte, Andrea
    Caravella, Giuseppe
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2020, 16 (06) : 1457 - 1458
  • [2] Tocilizumab for severe COVID-19 pneumonia
    Mourad, Jean-Jacques
    Azria, Philippe
    [J]. LANCET RHEUMATOLOGY, 2020, 2 (11): : E659 - E659
  • [3] Repurposed Tocilizumab in Patients with Severe COVID-19
    Tian, Jianbo
    Zhang, Ming
    Jin, Meng
    Zhang, Fengqin
    Chu, Qian
    Wang, Xiaoyang
    Chen, Can
    Yue, Huihui
    Zhang, Li
    Du, Ronghui
    Zhao, Dong
    Zeng, Zhaofu
    Zhao, Yang
    Liu, Kui
    Wang, Mengmei
    Hu, Ke
    Miao, Xiaoping
    Zhang, Huilan
    [J]. JOURNAL OF IMMUNOLOGY, 2021, 206 (03): : 599 - 606
  • [4] Tocilizumab is recommended for the treatment of severe COVID-19
    Zhou, Yonggang
    Wei, Haiming
    [J]. EBIOMEDICINE, 2020, 61
  • [5] Tocilizumab, Adipokines and Severe Complications of COVID-19
    Fioravanti, Antonella
    Porcelli, Brunetta
    Terzuoli, Lucia
    Bacarelli, Maria Romana
    Tenti, Sara
    Cheleschi, Sara
    [J]. CLINICAL DRUG INVESTIGATION, 2020, 40 (09) : 891 - 892
  • [6] Tocilizumab, Adipokines and Severe Complications of COVID-19
    Antonella Fioravanti
    Brunetta Porcelli
    Lucia Terzuoli
    Maria Romana Bacarelli
    Sara Tenti
    Sara Cheleschi
    [J]. Clinical Drug Investigation, 2020, 40 : 891 - 892
  • [7] Management of severe covid-19: progress and promise
    Lee, Cheryl K.
    Linder, Jeffrey A.
    Gates, Khalilah L.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 373
  • [8] Impact of tocilizumab administration on mortality in severe COVID-19
    Andrew Tsai
    Oumou Diawara
    Ronald G. Nahass
    Luigi Brunetti
    [J]. Scientific Reports, 10
  • [9] Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
    Rosas, I. O.
    Brau, N.
    Waters, M.
    Go, R. C.
    Hunter, B. D.
    Bhagani, S.
    Skiest, D.
    Aziz, M. S.
    Cooper, N.
    Douglas, I. S.
    Savic, S.
    Youngstein, T.
    Del Sorbo, L.
    Gracian, A. Cubillo
    De la Zerda, D. J.
    Ustianowski, A.
    Bao, M.
    Dimonaco, S.
    Graham, E.
    Matharu, B.
    Spotswood, H.
    Tsai, L.
    Malhotra, A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16): : 1503 - 1516
  • [10] Impact of tocilizumab administration on mortality in severe COVID-19
    Tsai, Andrew
    Diawara, Oumou
    Nahass, Ronald G.
    Brunetti, Luigi
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
12345